ArticleNature cancer2026

Erythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial.

Xiaoqian Nie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.